ArticleEJNMMI physics2017
Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey.
Article in EJNMMI physics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 87 citations in OpenAlex.
- Evaluation of segmentation accuracy and the improvement of time effectiveness using deep learning-based segmentation inEJNMMI physics · 2026Article
- Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- Radioligand therapies in meningioma: Evidence and future directions.Neuro-oncology · 2024Review
- Do we need dosimetry for the optimization of theranostics in CNS tumors?Neuro-oncology · 2024Review
- Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE).Cardiovascular and interventional radiology · 2024Article
- The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- Activity quantification and dosimetry in radiopharmaceutical therapy with reference toFrontiers in nuclear medicine · 2024Review
- Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023.Theranostics · 2024Review
- Gamma camera-specific reference standards for radioactive iodine uptake measurements.EJNMMI physics · 2023Article
- Cure of Disseminated Human Lymphoma with [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023Article
- A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [European journal of nuclear medicine and molecular imaging · 2023Article
- Evolution of Portable Sensors for In-Vivo Dose and Time-Activity Curve Monitoring as Tools for Personalized Dosimetry in Molecular Radiotherapy.Sensors (Basel, Switzerland) · 2023Review
- Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model UsingJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023Article
- Milestones in dosimetry for nuclear medicine therapy.The British journal of radiology · 2022Review
- EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.European journal of nuclear medicine and molecular imaging · 2022Article
- A mesh-based model of liver vasculature: implications for improved radiation dosimetry to liver parenchyma for radiopharmaceuticals.EJNMMI physics · 2022Article
- Exploring the translational challenge for medical applications of ionising radiation and corresponding radiation protection research.Journal of translational medicine · 2022Article
- Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors.Cancers · 2022Review
- Personalized Dosimetry in Targeted Radiation Therapy: A Look to Methods, Tools and Critical Aspects.Journal of personalized medicine · 2022Review
- Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021Review
Corrections and comments
- Commented on by
Authors and funding
13 authors at 13 institutions in 9 countries.
Funding
Abstract
backgroundCurrently, the implementation of dosimetry in molecular radiotherapy (MRT) is not well investigated, and in view of the Council Directive (2013/59/Euratom), there is a need to understand the current availability of dosimetry-based MRT in clinical practice and research studies. The aim of this study was to assess the current practice of MRT and dosimetry across European countries.
methodsAn electronic questionnaire was distributed to European countries. This addressed 18 explicitly considered therapies, and for each therapy, a similar set of questions were included. Questions covered the number of patients and treatments during 2015, involvement of medical specialties and medical physicists, implementation of absorbed dose planning, post-therapy imaging and dosimetry, and the basis of therapy prescription.
resultsResponses were obtained from 26 countries and 208 hospitals, administering in total 42,853 treatments. The most common therapies were
conclusionsThere is a wide variation in MRT practice across Europe and for different therapies, including the extent of medical-physicist involvement and the implementation of dosimetry-guided treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.